GlassScriptPhysician profile
Phillip A Rozeman
NPI 1699740035
$4,157.36
in general payments reported to CMS, 2019-2025
37 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $243 · 2021: $263 · 2022: $402 · 2023: $727 · 2024: $1,193 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $571.84 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $376.09 | 2020-2025 | |
| Abiomed | $324.25 | 2023-2025 | Impella |
| Medtronic, INC. | $284.46 | 2022-2025 | Reveal Linq, Onyx Frontier, Cobalt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $281.80 | 2021-2025 | Verquvo |
| Terumo Medical Corporation | $275.52 | 2019 | |
| Inari Medical, INC. | $214.95 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $176.44 | 2022-2024 | Avvigo Guidance System, Ekosonic, Ranger |
| E.R. Squibb & Sons, L.L.C. | $175.42 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $155.73 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $155.27 | 2019-2021 | |
| Irhythm Technologies, INC. | $122.54 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $117.42 | 2023-2024 | Inpefa |
| Pfizer INC. | $104.40 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.90 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $71.62 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.09 | 2021-2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $65.28 | 2024-2025 | Assure Wcd |
| Scpharmaceuticals INC. | $55.45 | 2023-2025 | |
| Stryker Corporation | $44.88 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ionis Pharmaceuticals, INC. | $43.44 | 2025 | Tryngolza |
| Philips North America LLC | $43.09 | 2025 | Ecc Solutions, Mcot |
| Janssen Pharmaceuticals, INC | $40.24 | 2022-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $38.23 | 2020-2025 | Amvuttra |
| Preventice Services, LLC | $29.82 | 2020 | |
| Esperion Therapeutics, INC. | $28.36 | 2021-2024 | Nexletol |
| Medtronic Vascular, INC. | $28.22 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $24.94 | 2019-2023 | Opsumit |
| Itamar Medical INC | $24.65 | 2025 | Watchpatone |
| Kiniksa Pharmaceuticals International, Plc | $23.97 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $19.74 | 2019 | |
| Zoll Circulation INC | $18.34 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Recor Medical INC | $16.39 | 2025 | Paradise Ultrasound Renal Denervation System |
| Astellas Pharma US INC | $13.57 | 2019 | |
| Ge Healthcare | $12.92 | 2021 | |
| Bardy Diagnostics, INC. | $10.09 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Rozeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.